Company: FEAV
Filing Date: 2025-03-27
Form Type: 424B3
Source: 0001193125-25-065503
Chunk: 18

Company: 5E Advanced Materials, Inc.
Filing Date: 2025-03-27
Form: 424B3
Chunk 18
---
 or issuable to such party in connection with its exercise of the warrants issued to such party on March 13, 2025, and otherwise without regard to any of the limitations on exercise of such warrants. The size of our Board was also reduced to four directors pursuant to the terms of this agreement. 16

SELLING STOCKHOLDERS

This prospectus relates to the offer and resale from time to time by the Selling Stockholders of up to 20,627,389 shares of common stock,
consisting of (i) 13,586,524 shares of common stock issued to the Selling Stockholders pursuant to the Exchange Agreement, (ii) 1,408,173 shares of common stock issued to the Selling Stockholders pursuant to the Subscription Agreement and
(iii) up to 5,632,692 shares of common stock issuable upon exercise of warrants issued to the Selling Stockholders pursuant to the Subscription Agreement.

The Selling Stockholders may from time to time offer and sell any or all of the Resale Shares set forth below pursuant to this prospectus and
any applicable prospectus supplement. When we refer to the “Selling Stockholders” in this prospectus, we mean the persons and entities listed in the table below, and the pledgee(s), donee(s), transferee(s), assignee(s), successor(s) and
others who later come to hold any of the Selling Stockholders’ interest in our securities after the date of this prospectus.

The
following table sets forth, as of March 14, 2025, the names of the Selling Stockholders, the aggregate number of shares of common stock beneficially owned by the Selling Stockholders, the number of shares of common stock that may be sold by the
Selling Stockholders under this prospectus and the number of shares of Common stock that the Selling Stockholders will beneficially own after this offering. For purposes of the table below, we have assumed that after this offering, none of the
shares of common stock covered by this prospectus will be beneficially owned by the Selling Stockholders. In addition, we assume that the Selling Stockholders have not sold, transferred or otherwise disposed of, our securities in transactions exempt
from the registration requirements of the Securities Act.

We cannot advise you as to whether the Selling Stockholders will sell any or
all of such shares of common stock. In addition, the Selling Stockholders may sell, transfer or otherwise dispose of, at any time and from time to time, the Res